<DOC>
	<DOCNO>NCT00301600</DOCNO>
	<brief_summary>A single-center random parallel study compare efficacy safety Mycophenolate mofetil versus intravenous Cyclophosphamide pulse treatment crescentic IgA nephropathy</brief_summary>
	<brief_title>Mycophenolate Mofetil Versus Intravenous Cyclophosphamide Pulses Treatment Crescentic IgA Nephropathy</brief_title>
	<detailed_description>IgA nephropathy immune-complex glomerulopathy result capillary necrosis extracapillary proliferation ( crescent ) . Several study document high incidence hypertension nephritic-range proteinuria patient crescentic form IgA nephropathy , suggest patient variant disease may worse prognosis . Some study show treatment steroid cyclophosphamide efficacy reduce proteinuria preserve renal function heal vasculitic lesion , therefore prevent progression glomerular sclerosis . Recent study also show mycophenolate mofetil effective treatment lupus nephritis vasculitic lesion small vasculitis renal involvement . We conduct single-center prospective open-labeled clinical trial 40 patient crescentic IgA nephropathy treat randomly pulse intravenous cyclophosphamide oral mycophenolate mofetil . After 12 month treatment , assess efficacy , safety , tolerability relapse mycophenolate mofetil compare cyclophosphamide treatment crescentic IgA nephropathy .</detailed_description>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Glomerulonephritis , IGA</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Patient diagnosis IgAN without deposition C4 C1q , age 1070y , sex free 1 . Gross hematuria active urine sediment 2 . Segmental necrotizing lesion capillary wall 3 . Cellular fibrocellular crescent ≥ 10 % 4 . Fibrinoid degeneration small vessel 5 . Fibrin positive Three item , provision criterion inform consent 1 . More fourweek treatment cytotoxic drug , CTX , CsA MMF , prior enrollment 2 . Immune deficiency 3 . Serum creatinine ≥ 5.0mg/dl 4 . Previous malignancy 5 . Pregnancy 6 . Hepatitis 7 . Diabetic mellitus obesity 8 . Severe infection CVS complication 9 . HenochSchonlein purpura nephritis , systemic vasculitis , SLE</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2008</verification_date>
	<keyword>Crescentic IgA nephropathy</keyword>
	<keyword>Mycophenolate mofetil</keyword>
	<keyword>Cyclophosphamide</keyword>
	<keyword>treatment</keyword>
</DOC>